Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Essential role of obscurin kinase-1 in cardiomyocyte coupling via N-cadherin phosphorylation
Li Wang, Panagiotis Tsakiroglou, Rex Gonzales, Suhan Cho, Amy Li, Cristobal dos Remedios, Nathan Wright, Aikaterini Kontrogianni-Konstantopoulos
Li Wang, Panagiotis Tsakiroglou, Rex Gonzales, Suhan Cho, Amy Li, Cristobal dos Remedios, Nathan Wright, Aikaterini Kontrogianni-Konstantopoulos
View: Text | PDF
Research Article Cell biology

Essential role of obscurin kinase-1 in cardiomyocyte coupling via N-cadherin phosphorylation

  • Text
  • PDF
Abstract

Obscurins are giant cytoskeletal proteins with structural and regulatory roles. Obscurin-B (~870 kDa), the largest known isoform, contains 2 enzymatically active Ser/Thr kinase (kin) domains, kin1 and kin2, which belong to the myosin light chain kinase family. Kin1 binds to and phosphorylates N-cadherin, a major component of the intercalated disc, the unique sarcolemmal microdomain that mediates the mechanochemical coupling of adjacent cardiomyocytes. Obscurin-B containing kin1 and N-cadherin colocalize at cell junctions in embryonic rat ventricular myocytes (ERVMs), and their codistribution is regulated by Ca2+. Phosphoproteomics analysis revealed that obscurin-kin1 phosphorylates N-cadherin at Ser-788 located within the juxtamembrane region of its cytoplasmic domain, with an apparent Kcat of approximately 5.05 min–1. Overexpression of obscurin-kin1 or phosphomimic-Ser-788-Glu N-cadherin in ERVMs markedly increases cell adhesion and chemical coupling. Importantly, phosphomimic Ser-788-Glu N-cadherin exhibits significantly reduced binding to p120-catenin, while overexpression of phosphoablated Ser-788-Ala N-cadherin increases RhoA activity. Consistent with an essential role of the obscurin-kin1/N-cadherin axis in cardiomyocyte coupling, it is deregulated in end-stage human heart failure. Given the nearly ubiquitous expression of obscurin and N-cadherin, our findings may have broad applicability in deciphering the obscurin-kin1/N-cadherin axis that likely mediates cell coupling in diverse tissues and organs.

Authors

Li Wang, Panagiotis Tsakiroglou, Rex Gonzales, Suhan Cho, Amy Li, Cristobal dos Remedios, Nathan Wright, Aikaterini Kontrogianni-Konstantopoulos

×

Figure 6

Impact of the N-cadherin/p120-catenin binding on RhoA activity.

Options: View larger image (or click on image) Download as PowerPoint
Impact of the N-cadherin/p120-catenin binding on RhoA activity.
(A) Mode...
(A) Model of the p120-catenin–bound N-cadherin D774–H791 fragment, based on the p120-catenin/E-cadherin structure (PDB: 3L6X), showing an extended conformation with a COOH-terminal 3-10 helix. (B and C) When the phosphomimic E778 is included in molecular dynamic simulations of this p120-catenin/N-cadherin complex, the 3-10 helix that supports hydrophobic interactions with p120-catenin loses multiple stabilizing hydrogen bonds. (D) This loss of hydrogen bonds destabilizes the helix, resulting in more motion and weaker interactions with the corresponding hydrophobic patch on p120-catenin, relative to simulations performed on the WT complex. (E) Representative immunoblot using protein lysates prepared from HEK293 cells transfected with control GFP or full-length WT (GFP-Ncad-WT), phosphomimic (GFP-Ncad-SE) or phosphoablated (GFP-Ncad-SA) N-cadherin constructs indicate similar levels of total RhoA across all groups; GAPDH was used as loading control (n = 3). Data are expressed as mean ± SEM and 1-way ANOVA followed by Fisher’s LSD test was used for statistical evaluation. (F) Measurement of GTP-RhoA levels (i.e., active RhoA) using luminescence-based G-LISA indicated that overexpression of phosphoablated GFP-Ncad-SA in HEK293 cells results in significantly increased RhoA activity compared with GFP and GFP-Ncad-SE; of note, GFP-Ncad-WT behaves similarly to GFP-Ncad-SA; n = 4 experiments performed in duplicate. Data are expressed as mean ± SEM and statistical evaluation was done with 1-way ANOVA followed by a Fisher’s LSD test, *P = 0.0104 for GFP vs. GFP-Ncad-WT, *P = 0.0189 for GFP-Ncad-WT vs. GFP-Ncad-SE, *P = 0.006 for GFP-Ncad-SE vs. GFP-Ncad-SA, and *P = 0.0033 for GFP vs. GFP-Ncad-SA.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts